← Back
Data updated: Mar 10, 2026
BIOVAIL
Pharmaceuticals
BIOVAIL is a specialty pharmaceutical company with 5 FDA-approved products.
1961
Since
5
Drugs
-
Trials
28
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
DILTIAZEM HYDROCHLORIDE 2026-02-23
Labeling
DILTIAZEM HYDROCHLORIDE 2026-02-23
Labeling
DILTIAZEM HYDROCHLORIDE 2026-01-24
Labeling
DILTIAZEM HYDROCHLORIDE 2026-01-24
Labeling
DILTIAZEM HYDROCHLORIDE 2026-01-18
Labeling
DILTIAZEM HYDROCHLORIDE 2025-11-14
DILTIAZEM HYDROCHLORIDE 2025-09-11
Labeling
DILTIAZEM HYDROCHLORIDE 2025-09-11
Labeling
DILTIAZEM HYDROCHLORIDE 2025-09-11
Labeling
DILTIAZEM HYDROCHLORIDE 2025-08-08
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
No indication data
Pipeline Strength Pro
Loading...
Active (0)
Discontinued (5)
Company Info
- First Approval
- 1961-12-20
- Latest
- 2003-03-21
- Applications
- 6